

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * tricarboxylic acid cycle (GO:0006099) | 6.38472377 |
| 2 | lysine metabolic process (GO:0006553) | 5.72192001 |
| 3 | lysine catabolic process (GO:0006554) | 5.72192001 |
| 4 | NADH metabolic process (GO:0006734) | 5.56713976 |
| 5 | 2-oxoglutarate metabolic process (GO:0006103) | 5.10161882 |
| 6 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.05907079 |
| 7 | oxaloacetate metabolic process (GO:0006107) | 5.00483108 |
| 8 | aspartate family amino acid catabolic process (GO:0009068) | 4.87207412 |
| 9 | carnitine shuttle (GO:0006853) | 4.77637255 |
| 10 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.73595078 |
| 11 | * succinate metabolic process (GO:0006105) | 4.70097965 |
| 12 | actin-myosin filament sliding (GO:0033275) | 4.65273707 |
| 13 | muscle filament sliding (GO:0030049) | 4.65273707 |
| 14 | Golgi transport vesicle coating (GO:0048200) | 4.58372663 |
| 15 | COPI coating of Golgi vesicle (GO:0048205) | 4.58372663 |
| 16 | fatty acid transmembrane transport (GO:1902001) | 4.56859140 |
| 17 | fatty acid beta-oxidation (GO:0006635) | 4.49350260 |
| 18 | regulation of coenzyme metabolic process (GO:0051196) | 4.46012236 |
| 19 | regulation of cofactor metabolic process (GO:0051193) | 4.46012236 |
| 20 | tricarboxylic acid metabolic process (GO:0072350) | 4.35025140 |
| 21 | cellular ketone body metabolic process (GO:0046950) | 4.17546833 |
| 22 | valine metabolic process (GO:0006573) | 4.16373033 |
| 23 | acetyl-CoA metabolic process (GO:0006084) | 4.12795936 |
| 24 | creatine metabolic process (GO:0006600) | 4.10146657 |
| 25 | short-chain fatty acid metabolic process (GO:0046459) | 4.09708599 |
| 26 | proline biosynthetic process (GO:0006561) | 4.09026880 |
| 27 | branched-chain amino acid catabolic process (GO:0009083) | 4.05441920 |
| 28 | regulation of relaxation of muscle (GO:1901077) | 4.03490608 |
| 29 | fatty acid oxidation (GO:0019395) | 4.01202835 |
| 30 | fatty acid catabolic process (GO:0009062) | 3.99383182 |
| 31 | lipid oxidation (GO:0034440) | 3.94094579 |
| 32 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.92242229 |
| 33 | L-phenylalanine catabolic process (GO:0006559) | 3.92242229 |
| 34 | urea cycle (GO:0000050) | 3.89732653 |
| 35 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.89682061 |
| 36 | L-phenylalanine metabolic process (GO:0006558) | 3.89682061 |
| 37 | branched-chain amino acid metabolic process (GO:0009081) | 3.89114327 |
| 38 | regulation of fatty acid oxidation (GO:0046320) | 3.86678389 |
| 39 | alpha-linolenic acid metabolic process (GO:0036109) | 3.86483218 |
| 40 | glyoxylate metabolic process (GO:0046487) | 3.83983469 |
| 41 | carnitine transport (GO:0015879) | 3.74831142 |
| 42 | amino-acid betaine transport (GO:0015838) | 3.74831142 |
| 43 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.74419974 |
| 44 | carnitine transmembrane transport (GO:1902603) | 3.74205554 |
| 45 | nitrogen cycle metabolic process (GO:0071941) | 3.73887554 |
| 46 | urea metabolic process (GO:0019627) | 3.72895443 |
| 47 | glycolytic process (GO:0006096) | 3.72372978 |
| 48 | biotin metabolic process (GO:0006768) | 3.67666027 |
| 49 | monocarboxylic acid catabolic process (GO:0072329) | 3.65318794 |
| 50 | amino-acid betaine metabolic process (GO:0006577) | 3.64624553 |
| 51 | ketone body metabolic process (GO:1902224) | 3.61531327 |
| 52 | regulation of sulfur metabolic process (GO:0042762) | 3.60910861 |
| 53 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.60518929 |
| 54 | regulation of sequestering of triglyceride (GO:0010889) | 3.60077499 |
| 55 | carnitine metabolic process (GO:0009437) | 3.58396411 |
| 56 | actin-mediated cell contraction (GO:0070252) | 3.57921588 |
| 57 | regulation of actin filament-based movement (GO:1903115) | 3.56513780 |
| 58 | folic acid metabolic process (GO:0046655) | 3.52998978 |
| 59 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.47043230 |
| 60 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.46123533 |
| 61 | positive regulation of fatty acid oxidation (GO:0046321) | 3.42258920 |
| 62 | fatty acid homeostasis (GO:0055089) | 3.39155142 |
| 63 | kynurenine metabolic process (GO:0070189) | 3.37807090 |
| 64 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.35300343 |
| 65 | sarcomere organization (GO:0045214) | 3.34061062 |
| 66 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.33742934 |
| 67 | oxidative phosphorylation (GO:0006119) | 3.33440430 |
| 68 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.31651733 |
| 69 | dicarboxylic acid catabolic process (GO:0043649) | 3.30461331 |
| 70 | skeletal muscle contraction (GO:0003009) | 3.29076931 |
| 71 | aromatic amino acid family catabolic process (GO:0009074) | 3.27351256 |
| 72 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.27334763 |
| 73 | gluconeogenesis (GO:0006094) | 3.27189509 |
| 74 | glutamate metabolic process (GO:0006536) | 3.26574860 |
| 75 | cardiac myofibril assembly (GO:0055003) | 3.25824955 |
| 76 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.25063272 |
| 77 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.23920757 |
| 78 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.23803645 |
| 79 | striated muscle contraction (GO:0006941) | 3.23514389 |
| 80 | quaternary ammonium group transport (GO:0015697) | 3.23046692 |
| 81 | regulation of triglyceride catabolic process (GO:0010896) | 3.22445599 |
| 82 | fructose metabolic process (GO:0006000) | 3.19893518 |
| 83 | mitochondrial fusion (GO:0008053) | 3.19185590 |
| 84 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.18414329 |
| 85 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.17249090 |
| 86 | acyl-CoA biosynthetic process (GO:0071616) | 3.13893315 |
| 87 | thioester biosynthetic process (GO:0035384) | 3.13893315 |
| 88 | cardiac muscle contraction (GO:0060048) | 3.13657426 |
| 89 | GDP-mannose metabolic process (GO:0019673) | 3.13013516 |
| 90 | ethanol oxidation (GO:0006069) | 3.12287183 |
| 91 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.12106795 |
| 92 | alpha-amino acid catabolic process (GO:1901606) | 3.11977216 |
| 93 | proline metabolic process (GO:0006560) | 3.10834367 |
| 94 | cellular polysaccharide catabolic process (GO:0044247) | 3.10785420 |
| 95 | cysteine metabolic process (GO:0006534) | 3.10072532 |
| 96 | actin filament depolymerization (GO:0030042) | 3.08875951 |
| 97 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.08839188 |
| 98 | organic acid catabolic process (GO:0016054) | 3.08058273 |
| 99 | carboxylic acid catabolic process (GO:0046395) | 3.08058273 |
| 100 | cellular amino acid catabolic process (GO:0009063) | 3.08007056 |
| 101 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.06941105 |
| 102 | protein maturation by protein folding (GO:0022417) | 3.04477169 |
| 103 | pyruvate metabolic process (GO:0006090) | 3.04084916 |
| 104 | sulfur amino acid catabolic process (GO:0000098) | 3.03956136 |
| 105 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.02191372 |
| 106 | regulation of translational fidelity (GO:0006450) | 3.00863524 |
| 107 | hexose biosynthetic process (GO:0019319) | 3.00835326 |
| 108 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.98208928 |
| 109 | protein retention in ER lumen (GO:0006621) | 2.97093884 |
| 110 | * respiratory electron transport chain (GO:0022904) | 2.96232084 |
| 111 | thioester metabolic process (GO:0035383) | 2.95233214 |
| 112 | acyl-CoA metabolic process (GO:0006637) | 2.95233214 |
| 113 | galactose catabolic process (GO:0019388) | 2.94688460 |
| 114 | bile acid biosynthetic process (GO:0006699) | 2.93127266 |
| 115 | mitotic chromosome condensation (GO:0007076) | 2.90876216 |
| 116 | cell communication by electrical coupling (GO:0010644) | 2.90461349 |
| 117 | NAD metabolic process (GO:0019674) | 2.89113638 |
| 118 | * electron transport chain (GO:0022900) | 2.87790597 |
| 119 | citrulline biosynthetic process (GO:0019240) | 2.87694571 |
| 120 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.87536958 |
| 121 | DNA unwinding involved in DNA replication (GO:0006268) | 2.86573554 |
| 122 | regulation of cell communication by electrical coupling (GO:0010649) | 2.86344337 |
| 123 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.86300322 |
| 124 | 4-hydroxyproline metabolic process (GO:0019471) | 2.83985200 |
| 125 | homocysteine metabolic process (GO:0050667) | 2.83926878 |
| 126 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.83671605 |
| 127 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.83110207 |
| 128 | cell communication involved in cardiac conduction (GO:0086065) | 2.82349996 |
| 129 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.81980994 |
| 130 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.81654204 |
| 131 | tryptophan catabolic process (GO:0006569) | 2.81597035 |
| 132 | indole-containing compound catabolic process (GO:0042436) | 2.81597035 |
| 133 | indolalkylamine catabolic process (GO:0046218) | 2.81597035 |
| 134 | glycogen catabolic process (GO:0005980) | 2.81186753 |
| 135 | regulation of mitotic spindle organization (GO:0060236) | 2.80695923 |
| 136 | monosaccharide biosynthetic process (GO:0046364) | 2.79782626 |
| 137 | myofibril assembly (GO:0030239) | 2.78727453 |
| 138 | cellular modified amino acid catabolic process (GO:0042219) | 2.77850033 |
| 139 | coenzyme catabolic process (GO:0009109) | 2.77533649 |
| 140 | skeletal muscle adaptation (GO:0043501) | 2.76596924 |
| 141 | DNA strand elongation (GO:0022616) | 2.76123837 |
| 142 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.75693620 |
| 143 | polysaccharide catabolic process (GO:0000272) | 2.75564476 |
| 144 | pentose-phosphate shunt (GO:0006098) | 2.74899142 |
| 145 | glucan catabolic process (GO:0009251) | 2.74650672 |
| 146 | positive regulation of lipid catabolic process (GO:0050996) | 2.73741800 |
| 147 | regulation of fatty acid metabolic process (GO:0019217) | 2.73377440 |
| 148 | desmosome organization (GO:0002934) | 2.72282448 |
| 149 | nuclear pore complex assembly (GO:0051292) | 2.72033866 |
| 150 | actomyosin structure organization (GO:0031032) | 2.71343678 |
| 151 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.69628008 |
| 152 | citrulline metabolic process (GO:0000052) | 2.65867134 |
| 153 | regulation of mitochondrial translation (GO:0070129) | 2.65423993 |
| 154 | actin filament-based movement (GO:0030048) | 2.64169482 |
| 155 | cell-substrate adherens junction assembly (GO:0007045) | 2.63937094 |
| 156 | focal adhesion assembly (GO:0048041) | 2.63937094 |
| 157 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.62047319 |
| 158 | regulation of cholesterol metabolic process (GO:0090181) | 2.59492744 |
| 159 | glucose 6-phosphate metabolic process (GO:0051156) | 2.59246369 |
| 160 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.58810141 |
| 161 | regulation of skeletal muscle contraction (GO:0014819) | 2.55367613 |
| 162 | negative regulation of cell size (GO:0045792) | 2.54299384 |
| 163 | negative regulation of necroptotic process (GO:0060546) | 2.53291962 |
| 164 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.51858823 |
| 165 | glucose metabolic process (GO:0006006) | 2.49630132 |
| 166 | * dicarboxylic acid metabolic process (GO:0043648) | 2.49561193 |
| 167 | response to muscle activity (GO:0014850) | 2.49306503 |
| 168 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.47660315 |
| 169 | quinone biosynthetic process (GO:1901663) | 2.47596888 |
| 170 | glucose catabolic process (GO:0006007) | 2.46805519 |
| 171 | regulation of the force of heart contraction (GO:0002026) | 2.46406766 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 7.95782903 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.43440130 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.03252770 |
| 4 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.58266773 |
| 5 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.43534602 |
| 6 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 4.13229648 |
| 7 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.00015318 |
| 8 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.97365629 |
| 9 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.46168716 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.17795594 |
| 11 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.15356892 |
| 12 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.45593936 |
| 13 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.33784430 |
| 14 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.30938332 |
| 15 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.23405014 |
| 16 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.10428627 |
| 17 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.09304120 |
| 18 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.04174538 |
| 19 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.00594508 |
| 20 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.93245306 |
| 21 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.91214188 |
| 22 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.82457049 |
| 23 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.81221757 |
| 24 | GATA1_22025678_ChIP-Seq_K562_Human | 1.80952846 |
| 25 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.79629938 |
| 26 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.79489238 |
| 27 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.75963493 |
| 28 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.75259463 |
| 29 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.68753547 |
| 30 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.67631538 |
| 31 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.67098999 |
| 32 | MYC_22102868_ChIP-Seq_BL_Human | 1.66113376 |
| 33 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.65729656 |
| 34 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.64960457 |
| 35 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.64012412 |
| 36 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.63844878 |
| 37 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.63844878 |
| 38 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.62030211 |
| 39 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.60266709 |
| 40 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.59870802 |
| 41 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.59368767 |
| 42 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.57782317 |
| 43 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.57647980 |
| 44 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.56217513 |
| 45 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.55703236 |
| 46 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.55434543 |
| 47 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.51770315 |
| 48 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.50260312 |
| 49 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.49565392 |
| 50 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.47765322 |
| 51 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.46892104 |
| 52 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.45789379 |
| 53 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.44455699 |
| 54 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.43355052 |
| 55 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.41677161 |
| 56 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.41346046 |
| 57 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.38819000 |
| 58 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.37042227 |
| 59 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.36722964 |
| 60 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.36688134 |
| 61 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.36354247 |
| 62 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.34542263 |
| 63 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.34285799 |
| 64 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.33466869 |
| 65 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.33050230 |
| 66 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.32868476 |
| 67 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.30014819 |
| 68 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.29559613 |
| 69 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.28360715 |
| 70 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.27954745 |
| 71 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.27134978 |
| 72 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.25743351 |
| 73 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.25268947 |
| 74 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.23254766 |
| 75 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.22380667 |
| 76 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.22176255 |
| 77 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.21835515 |
| 78 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.21609623 |
| 79 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.21276308 |
| 80 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.21210877 |
| 81 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.19463402 |
| 82 | * TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.17414486 |
| 83 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.17096790 |
| 84 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.16859840 |
| 85 | ATF3_27146783_Chip-Seq_COLON_Human | 1.16126831 |
| 86 | * KDM5A_27292631_Chip-Seq_BREAST_Human | 1.15646761 |
| 87 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.14810595 |
| 88 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.13819949 |
| 89 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13653719 |
| 90 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.13211216 |
| 91 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.11000113 |
| 92 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.10578192 |
| 93 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.09785988 |
| 94 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.09564506 |
| 95 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.08605127 |
| 96 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.08425984 |
| 97 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.06173648 |
| 98 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.05931357 |
| 99 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.05600838 |
| 100 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.05276868 |
| 101 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.04596605 |
| 102 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.04389511 |
| 103 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.03863972 |
| 104 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.03639180 |
| 105 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.03607864 |
| 106 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.03223045 |
| 107 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.03095011 |
| 108 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02968097 |
| 109 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.02295216 |
| 110 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.02256450 |
| 111 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.00671429 |
| 112 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.99884161 |
| 113 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.99558487 |
| 114 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.98249473 |
| 115 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.98178783 |
| 116 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.97566947 |
| 117 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.97210439 |
| 118 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.96652761 |
| 119 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.96538045 |
| 120 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.95088995 |
| 121 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.93990514 |
| 122 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.93775673 |
| 123 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.91681818 |
| 124 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.91259802 |
| 125 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.90604314 |
| 126 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.89555703 |
| 127 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.89422645 |
| 128 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.87621813 |
| 129 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.87347023 |
| 130 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.85607598 |
| 131 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.85071863 |
| 132 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.82995854 |
| 133 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.82195164 |
| 134 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.80031047 |
| 135 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.80031047 |
| 136 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.79735200 |
| 137 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.78865677 |
| 138 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.78595589 |
| 139 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.74428908 |
| 140 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.73985615 |
| 141 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.73839392 |
| 142 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.73393523 |
| 143 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.73383392 |
| 144 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.72816157 |
| 145 | CBP_21632823_ChIP-Seq_H3396_Human | 0.71840018 |
| 146 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.71649670 |
| 147 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.71495329 |
| 148 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.71060750 |
| 149 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.70984655 |
| 150 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.70866661 |
| 151 | GATA1_19941826_ChIP-Seq_K562_Human | 0.69938861 |
| 152 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.68826283 |
| 153 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.68826283 |
| 154 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.68461146 |
| 155 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.67726182 |
| 156 | P68_20966046_ChIP-Seq_HELA_Human | 0.67425801 |
| 157 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.66332389 |
| 158 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.66140820 |
| 159 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.66121301 |
| 160 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.65467741 |
| 161 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.65243481 |
| 162 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.64685553 |
| 163 | AR_19668381_ChIP-Seq_PC3_Human | 0.64627765 |
| 164 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.63770299 |
| 165 | * SMC4_20622854_ChIP-Seq_HELA_Human | 0.63043287 |
| 166 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.62932771 |
| 167 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.62932771 |
| 168 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.62457739 |
| 169 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.61760397 |
| 170 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.61744493 |
| 171 | GATA2_19941826_ChIP-Seq_K562_Human | 0.60971690 |
| 172 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.60364797 |
| 173 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.60354156 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 4.73728893 |
| 2 | MP0005360_urolithiasis | 4.13177284 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 4.04187726 |
| 4 | MP0003646_muscle_fatigue | 3.88664879 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 3.24902162 |
| 6 | MP0000751_myopathy | 3.19962130 |
| 7 | MP0005451_abnormal_body_composition | 3.16384407 |
| 8 | MP0004084_abnormal_cardiac_muscle | 3.15719614 |
| 9 | MP0005365_abnormal_bile_salt | 3.10195843 |
| 10 | MP0004130_abnormal_muscle_cell | 2.94051012 |
| 11 | MP0004215_abnormal_myocardial_fiber | 2.91866869 |
| 12 | MP0004036_abnormal_muscle_relaxation | 2.78710370 |
| 13 | MP0008875_abnormal_xenobiotic_pharmacok | 2.76257566 |
| 14 | MP0002877_abnormal_melanocyte_morpholog | 2.50333740 |
| 15 | MP0003806_abnormal_nucleotide_metabolis | 2.48887363 |
| 16 | MP0006036_abnormal_mitochondrial_physio | 2.47685326 |
| 17 | MP0001661_extended_life_span | 2.47383443 |
| 18 | MP0005330_cardiomyopathy | 2.33978970 |
| 19 | MP0010329_abnormal_lipoprotein_level | 2.30757771 |
| 20 | MP0000749_muscle_degeneration | 2.27742972 |
| 21 | MP0005332_abnormal_amino_acid | 2.23016616 |
| 22 | MP0010234_abnormal_vibrissa_follicle | 2.22296063 |
| 23 | MP0004043_abnormal_pH_regulation | 2.08430977 |
| 24 | MP0005670_abnormal_white_adipose | 2.05086970 |
| 25 | MP0005058_abnormal_lysosome_morphology | 2.02087027 |
| 26 | MP0003195_calcinosis | 1.95592650 |
| 27 | MP0003252_abnormal_bile_duct | 1.93198599 |
| 28 | MP0002822_catalepsy | 1.87723648 |
| 29 | MP0008775_abnormal_heart_ventricle | 1.85414193 |
| 30 | MP0004087_abnormal_muscle_fiber | 1.82816106 |
| 31 | MP0002972_abnormal_cardiac_muscle | 1.81348900 |
| 32 | MP0005620_abnormal_muscle_contractility | 1.78690819 |
| 33 | MP0005666_abnormal_adipose_tissue | 1.73240833 |
| 34 | MP0002269_muscular_atrophy | 1.72617490 |
| 35 | MP0003111_abnormal_nucleus_morphology | 1.67668001 |
| 36 | MP0006035_abnormal_mitochondrial_morpho | 1.67252016 |
| 37 | MP0002118_abnormal_lipid_homeostasis | 1.62946152 |
| 38 | MP0003693_abnormal_embryo_hatching | 1.61846687 |
| 39 | MP0010094_abnormal_chromosome_stability | 1.60808072 |
| 40 | MP0000747_muscle_weakness | 1.60710667 |
| 41 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.57176339 |
| 42 | MP0003137_abnormal_impulse_conducting | 1.53474640 |
| 43 | MP0004484_altered_response_of | 1.51792664 |
| 44 | MP0005408_hypopigmentation | 1.51767488 |
| 45 | MP0001544_abnormal_cardiovascular_syste | 1.50433962 |
| 46 | MP0005385_cardiovascular_system_phenoty | 1.50433962 |
| 47 | MP0006138_congestive_heart_failure | 1.50140261 |
| 48 | MP0004145_abnormal_muscle_electrophysio | 1.47942330 |
| 49 | MP0004859_abnormal_synaptic_plasticity | 1.45259830 |
| 50 | MP0005535_abnormal_body_temperature | 1.44821980 |
| 51 | MP0000013_abnormal_adipose_tissue | 1.44737663 |
| 52 | MP0004233_abnormal_muscle_weight | 1.43989612 |
| 53 | MP0009840_abnormal_foam_cell | 1.41489670 |
| 54 | MP0009697_abnormal_copulation | 1.40541031 |
| 55 | MP0005319_abnormal_enzyme/_coenzyme | 1.40473579 |
| 56 | MP0004085_abnormal_heartbeat | 1.37458560 |
| 57 | MP0002971_abnormal_brown_adipose | 1.37242383 |
| 58 | MP0001666_abnormal_nutrient_absorption | 1.37115029 |
| 59 | MP0002909_abnormal_adrenal_gland | 1.36539931 |
| 60 | MP0002106_abnormal_muscle_physiology | 1.36492149 |
| 61 | MP0008260_abnormal_autophagy | 1.34558193 |
| 62 | MP0003221_abnormal_cardiomyocyte_apopto | 1.33371949 |
| 63 | MP0009780_abnormal_chondrocyte_physiolo | 1.27558910 |
| 64 | MP0005083_abnormal_biliary_tract | 1.27093358 |
| 65 | MP0004957_abnormal_blastocyst_morpholog | 1.26925730 |
| 66 | MP0003950_abnormal_plasma_membrane | 1.26217948 |
| 67 | MP0010630_abnormal_cardiac_muscle | 1.24115185 |
| 68 | MP0002078_abnormal_glucose_homeostasis | 1.22870122 |
| 69 | MP0003191_abnormal_cellular_cholesterol | 1.21718349 |
| 70 | MP0003329_amyloid_beta_deposits | 1.17525245 |
| 71 | MP0003077_abnormal_cell_cycle | 1.16694805 |
| 72 | MP0005375_adipose_tissue_phenotype | 1.15367473 |
| 73 | MP0008007_abnormal_cellular_replicative | 1.14805625 |
| 74 | MP0000609_abnormal_liver_physiology | 1.14603885 |
| 75 | MP0000678_abnormal_parathyroid_gland | 1.14436371 |
| 76 | MP0000759_abnormal_skeletal_muscle | 1.13334581 |
| 77 | MP0005076_abnormal_cell_differentiation | 1.12534333 |
| 78 | MP0008932_abnormal_embryonic_tissue | 1.12426719 |
| 79 | MP0002332_abnormal_exercise_endurance | 1.11714696 |
| 80 | MP0005369_muscle_phenotype | 1.11245637 |
| 81 | MP0000750_abnormal_muscle_regeneration | 1.11052031 |
| 82 | MP0009643_abnormal_urine_homeostasis | 1.09030686 |
| 83 | MP0000733_abnormal_muscle_development | 1.08896257 |
| 84 | MP0004185_abnormal_adipocyte_glucose | 1.07438895 |
| 85 | MP0005266_abnormal_metabolism | 1.07336413 |
| 86 | MP0000230_abnormal_systemic_arterial | 1.04778129 |
| 87 | MP0004147_increased_porphyrin_level | 1.02753259 |
| 88 | MP0003635_abnormal_synaptic_transmissio | 1.00280728 |
| 89 | MP0001730_embryonic_growth_arrest | 0.98684917 |
| 90 | MP0003566_abnormal_cell_adhesion | 0.98411609 |
| 91 | MP0008961_abnormal_basal_metabolism | 0.97665939 |
| 92 | MP0000358_abnormal_cell_content/ | 0.94575716 |
| 93 | MP0009745_abnormal_behavioral_response | 0.93867598 |
| 94 | MP0010352_gastrointestinal_tract_polyps | 0.92638818 |
| 95 | MP0004264_abnormal_extraembryonic_tissu | 0.92220330 |
| 96 | MP0002064_seizures | 0.90990546 |
| 97 | MP0009046_muscle_twitch | 0.90227533 |
| 98 | MP0004019_abnormal_vitamin_homeostasis | 0.90066156 |
| 99 | MP0001764_abnormal_homeostasis | 0.88523413 |
| 100 | MP0000003_abnormal_adipose_tissue | 0.85684484 |
| 101 | MP0005448_abnormal_energy_balance | 0.85340617 |
| 102 | MP0001765_abnormal_ion_homeostasis | 0.82578513 |
| 103 | MP0001756_abnormal_urination | 0.82572325 |
| 104 | MP0005334_abnormal_fat_pad | 0.80590828 |
| 105 | MP0005636_abnormal_mineral_homeostasis | 0.78529563 |
| 106 | MP0000604_amyloidosis | 0.77676744 |
| 107 | MP0002876_abnormal_thyroid_physiology | 0.77209248 |
| 108 | MP0003656_abnormal_erythrocyte_physiolo | 0.76570381 |
| 109 | MP0002080_prenatal_lethality | 0.76196080 |
| 110 | MP0005501_abnormal_skin_physiology | 0.74660981 |
| 111 | MP0004270_analgesia | 0.73997349 |
| 112 | MP0003705_abnormal_hypodermis_morpholog | 0.73949448 |
| 113 | MP0004924_abnormal_behavior | 0.73218603 |
| 114 | MP0005386_behavior/neurological_phenoty | 0.73218603 |
| 115 | MP0002063_abnormal_learning/memory/cond | 0.72815447 |
| 116 | MP0008872_abnormal_physiological_respon | 0.71793659 |
| 117 | MP0008874_decreased_physiological_sensi | 0.71564435 |
| 118 | MP0002272_abnormal_nervous_system | 0.71333407 |
| 119 | MP0001727_abnormal_embryo_implantation | 0.70662922 |
| 120 | MP0004782_abnormal_surfactant_physiolog | 0.68539816 |
| 121 | MP0003690_abnormal_glial_cell | 0.68295025 |
| 122 | MP0003984_embryonic_growth_retardation | 0.67859380 |
| 123 | MP0005165_increased_susceptibility_to | 0.67250819 |
| 124 | MP0003953_abnormal_hormone_level | 0.66722355 |
| 125 | MP0000350_abnormal_cell_proliferation | 0.66483805 |
| 126 | MP0001849_ear_inflammation | 0.65952612 |
| 127 | MP0004858_abnormal_nervous_system | 0.65848923 |
| 128 | MP0008058_abnormal_DNA_repair | 0.65181520 |
| 129 | MP0002108_abnormal_muscle_morphology | 0.64738438 |
| 130 | MP0005376_homeostasis/metabolism_phenot | 0.64326723 |
| 131 | MP0002088_abnormal_embryonic_growth/wei | 0.62905869 |
| 132 | MP0003186_abnormal_redox_activity | 0.62885551 |
| 133 | MP0002970_abnormal_white_adipose | 0.62765075 |
| 134 | MP0005452_abnormal_adipose_tissue | 0.62761174 |
| 135 | MP0003633_abnormal_nervous_system | 0.62583331 |
| 136 | MP0003763_abnormal_thymus_physiology | 0.62001368 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nemaline bodies (HP:0003798) | 5.14989830 |
| 2 | Muscle fiber inclusion bodies (HP:0100299) | 5.11398426 |
| 3 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 5.02663596 |
| 4 | Myoglobinuria (HP:0002913) | 4.80706612 |
| 5 | Exercise-induced myalgia (HP:0003738) | 4.51531515 |
| 6 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 4.38017329 |
| 7 | Ketoacidosis (HP:0001993) | 4.30810447 |
| 8 | Distal lower limb muscle weakness (HP:0009053) | 4.11255022 |
| 9 | Sudden death (HP:0001699) | 4.09722317 |
| 10 | Hypoglycemic coma (HP:0001325) | 4.06914313 |
| 11 | Exercise-induced muscle cramps (HP:0003710) | 4.06849698 |
| 12 | Ketosis (HP:0001946) | 4.05769620 |
| 13 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.94011869 |
| 14 | Hyperglycinuria (HP:0003108) | 3.92179211 |
| 15 | Hyperammonemia (HP:0001987) | 3.90163153 |
| 16 | Progressive muscle weakness (HP:0003323) | 3.78841698 |
| 17 | Myopathic facies (HP:0002058) | 3.78728010 |
| 18 | Increased connective tissue (HP:0009025) | 3.71126769 |
| 19 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.54837166 |
| 20 | Abnormality of glycine metabolism (HP:0010895) | 3.54837166 |
| 21 | Rhabdomyolysis (HP:0003201) | 3.51465249 |
| 22 | Type 1 muscle fiber predominance (HP:0003803) | 3.51130137 |
| 23 | Dicarboxylic aciduria (HP:0003215) | 3.47116338 |
| 24 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.47116338 |
| 25 | Distal lower limb amyotrophy (HP:0008944) | 3.46344915 |
| 26 | Palpitations (HP:0001962) | 3.32203843 |
| 27 | Neck muscle weakness (HP:0000467) | 3.30203080 |
| 28 | Calf muscle hypertrophy (HP:0008981) | 3.28566712 |
| 29 | Cerebral edema (HP:0002181) | 3.18985135 |
| 30 | Acute encephalopathy (HP:0006846) | 3.16935351 |
| 31 | * Hepatic necrosis (HP:0002605) | 3.12136040 |
| 32 | Gout (HP:0001997) | 3.11086194 |
| 33 | Pheochromocytoma (HP:0002666) | 3.10359244 |
| 34 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.08586235 |
| 35 | Hyperglycinemia (HP:0002154) | 3.05693187 |
| 36 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.99468374 |
| 37 | Ventricular tachycardia (HP:0004756) | 2.96731656 |
| 38 | Abnormality of glycolysis (HP:0004366) | 2.95995428 |
| 39 | Increased serum pyruvate (HP:0003542) | 2.95995428 |
| 40 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.92955549 |
| 41 | Generalized aminoaciduria (HP:0002909) | 2.88395565 |
| 42 | Xanthomatosis (HP:0000991) | 2.82884460 |
| 43 | Neuroendocrine neoplasm (HP:0100634) | 2.79794641 |
| 44 | Metabolic acidosis (HP:0001942) | 2.78496242 |
| 45 | Acute necrotizing encephalopathy (HP:0006965) | 2.77147486 |
| 46 | * Abnormal mitochondria in muscle tissue (HP:0008316) | 2.70010404 |
| 47 | Intrahepatic cholestasis (HP:0001406) | 2.69295112 |
| 48 | Lethargy (HP:0001254) | 2.68711439 |
| 49 | Atrial fibrillation (HP:0005110) | 2.68592219 |
| 50 | Deep venous thrombosis (HP:0002625) | 2.65823607 |
| 51 | Abnormality of the calf musculature (HP:0001430) | 2.63970463 |
| 52 | Conjunctival hamartoma (HP:0100780) | 2.61941493 |
| 53 | Asymmetric septal hypertrophy (HP:0001670) | 2.59605340 |
| 54 | Syncope (HP:0001279) | 2.58242607 |
| 55 | Abnormality of alanine metabolism (HP:0010916) | 2.57194185 |
| 56 | Hyperalaninemia (HP:0003348) | 2.57194185 |
| 57 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.57194185 |
| 58 | Right ventricular cardiomyopathy (HP:0011663) | 2.53919599 |
| 59 | * Lactic acidosis (HP:0003128) | 2.53594715 |
| 60 | Bundle branch block (HP:0011710) | 2.53338991 |
| 61 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.51720862 |
| 62 | Cholelithiasis (HP:0001081) | 2.49825398 |
| 63 | Primary atrial arrhythmia (HP:0001692) | 2.47553799 |
| 64 | Muscle fiber splitting (HP:0003555) | 2.45869865 |
| 65 | Hyporeflexia of lower limbs (HP:0002600) | 2.44620683 |
| 66 | Oligomenorrhea (HP:0000876) | 2.43031171 |
| 67 | Abnormal atrioventricular conduction (HP:0005150) | 2.42741452 |
| 68 | Hypoalphalipoproteinemia (HP:0003233) | 2.42650366 |
| 69 | Reticulocytosis (HP:0001923) | 2.42496537 |
| 70 | Hyperlipoproteinemia (HP:0010980) | 2.42221389 |
| 71 | Progressive macrocephaly (HP:0004481) | 2.40426513 |
| 72 | * Hepatocellular necrosis (HP:0001404) | 2.39620208 |
| 73 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.39578288 |
| 74 | Supraventricular tachycardia (HP:0004755) | 2.39034353 |
| 75 | Hypobetalipoproteinemia (HP:0003563) | 2.38120864 |
| 76 | Muscle stiffness (HP:0003552) | 2.37735056 |
| 77 | * Lipoatrophy (HP:0100578) | 2.37563904 |
| 78 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.37173033 |
| 79 | Ventricular arrhythmia (HP:0004308) | 2.36183187 |
| 80 | Abnormal gallbladder morphology (HP:0012437) | 2.34216360 |
| 81 | Vomiting (HP:0002013) | 2.33906154 |
| 82 | Supraventricular arrhythmia (HP:0005115) | 2.33608245 |
| 83 | Achilles tendon contracture (HP:0001771) | 2.33147340 |
| 84 | Hypolipoproteinemia (HP:0010981) | 2.31657365 |
| 85 | Ventricular fibrillation (HP:0001663) | 2.30822309 |
| 86 | Abnormal gallbladder physiology (HP:0012438) | 2.30394172 |
| 87 | Cholecystitis (HP:0001082) | 2.30394172 |
| 88 | Microvesicular hepatic steatosis (HP:0001414) | 2.29797691 |
| 89 | Ulnar deviation of the wrist (HP:0003049) | 2.29625582 |
| 90 | Calcaneovalgus deformity (HP:0001848) | 2.29511970 |
| 91 | Increased purine levels (HP:0004368) | 2.28688684 |
| 92 | Hyperuricemia (HP:0002149) | 2.28688684 |
| 93 | Dysmetric saccades (HP:0000641) | 2.28513211 |
| 94 | Abnormality of serum amino acid levels (HP:0003112) | 2.28192292 |
| 95 | Proximal tubulopathy (HP:0000114) | 2.28030450 |
| 96 | Prolonged QT interval (HP:0001657) | 2.27442243 |
| 97 | Difficulty running (HP:0009046) | 2.25817371 |
| 98 | Abnormality of purine metabolism (HP:0004352) | 2.25452256 |
| 99 | * Increased CSF lactate (HP:0002490) | 2.23094357 |
| 100 | Myotonia (HP:0002486) | 2.22938871 |
| 101 | * Increased muscle lipid content (HP:0009058) | 2.22922030 |
| 102 | EMG: myopathic abnormalities (HP:0003458) | 2.22194847 |
| 103 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.21996380 |
| 104 | Lower limb amyotrophy (HP:0007210) | 2.21445675 |
| 105 | Atrioventricular block (HP:0001678) | 2.20922610 |
| 106 | Abnormality of the Achilles tendon (HP:0005109) | 2.20329428 |
| 107 | * Dilated cardiomyopathy (HP:0001644) | 2.18977462 |
| 108 | Rimmed vacuoles (HP:0003805) | 2.18713663 |
| 109 | Heart block (HP:0012722) | 2.18156677 |
| 110 | Neoplasm of the adrenal gland (HP:0100631) | 2.16798687 |
| 111 | EMG: neuropathic changes (HP:0003445) | 2.14319872 |
| 112 | Foot dorsiflexor weakness (HP:0009027) | 2.12109692 |
| 113 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.11337795 |
| 114 | Vertebral compression fractures (HP:0002953) | 2.10177566 |
| 115 | Difficulty climbing stairs (HP:0003551) | 2.09852923 |
| 116 | Methylmalonic aciduria (HP:0012120) | 2.08963706 |
| 117 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.08490316 |
| 118 | Areflexia of lower limbs (HP:0002522) | 2.07062070 |
| 119 | Abnormality of the foot musculature (HP:0001436) | 2.06535039 |
| 120 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.06500393 |
| 121 | Subaortic stenosis (HP:0001682) | 2.06500393 |
| 122 | * Mitochondrial inheritance (HP:0001427) | 2.06074790 |
| 123 | Hyperventilation (HP:0002883) | 2.05702629 |
| 124 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.05039178 |
| 125 | * Ragged-red muscle fibers (HP:0003200) | 2.05013286 |
| 126 | Distal arthrogryposis (HP:0005684) | 2.04430706 |
| 127 | Hamartoma of the eye (HP:0010568) | 2.03418505 |
| 128 | Generalized muscle weakness (HP:0003324) | 2.02750807 |
| 129 | Skin nodule (HP:0200036) | 2.02599527 |
| 130 | Complement deficiency (HP:0004431) | 2.01706288 |
| 131 | Abnormality of the tricuspid valve (HP:0001702) | 1.99320478 |
| 132 | Increased variability in muscle fiber diameter (HP:0003557) | 1.99272444 |
| 133 | Trismus (HP:0000211) | 1.94943489 |
| 134 | Deformed tarsal bones (HP:0008119) | 1.90364991 |
| 135 | Bulbar palsy (HP:0001283) | 1.88527078 |
| 136 | Reduced antithrombin III activity (HP:0001976) | 1.86713753 |
| 137 | Abnormality of the calcaneus (HP:0008364) | 1.86164986 |
| 138 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.85396386 |
| 139 | * Exercise intolerance (HP:0003546) | 1.85164627 |
| 140 | Progressive external ophthalmoplegia (HP:0000590) | 1.84719472 |
| 141 | Hyperacusis (HP:0010780) | 1.77103810 |
| 142 | Scapular winging (HP:0003691) | 1.73724981 |
| 143 | Back pain (HP:0003418) | 1.71494029 |
| 144 | Abnormality of reticulocytes (HP:0004312) | 1.71007103 |
| 145 | Elbow flexion contracture (HP:0002987) | 1.68854868 |
| 146 | Hemorrhage of the eye (HP:0011885) | 1.68247554 |
| 147 | Round ear (HP:0100830) | 1.64426124 |
| 148 | Testicular atrophy (HP:0000029) | 1.64403708 |
| 149 | Cerebral palsy (HP:0100021) | 1.60552461 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 4.47803025 |
| 2 | PDK3 | 4.32629146 |
| 3 | PDK4 | 4.32629146 |
| 4 | NEK1 | 3.27349452 |
| 5 | LMTK2 | 3.24542236 |
| 6 | TRIB3 | 3.17281842 |
| 7 | PKN2 | 2.92885748 |
| 8 | TTN | 2.85194785 |
| 9 | PHKG2 | 2.77734396 |
| 10 | PHKG1 | 2.77734396 |
| 11 | SCYL2 | 2.67995328 |
| 12 | OBSCN | 2.66053163 |
| 13 | TESK2 | 2.55312183 |
| 14 | NME2 | 2.55302276 |
| 15 | PDK2 | 2.41404438 |
| 16 | EEF2K | 2.26540964 |
| 17 | EPHA2 | 2.24559474 |
| 18 | ICK | 2.24035105 |
| 19 | MYLK | 2.18784037 |
| 20 | MAP2K4 | 2.08151092 |
| 21 | ARAF | 2.05873122 |
| 22 | PINK1 | 1.95227109 |
| 23 | SMG1 | 1.89142346 |
| 24 | PBK | 1.85783235 |
| 25 | MAPKAPK3 | 1.84741932 |
| 26 | MAP3K4 | 1.75964035 |
| 27 | RPS6KB2 | 1.68373299 |
| 28 | IRAK3 | 1.68348308 |
| 29 | MET | 1.61215503 |
| 30 | NTRK3 | 1.57874958 |
| 31 | EIF2AK1 | 1.55155981 |
| 32 | WNK4 | 1.53323830 |
| 33 | PIM2 | 1.49796493 |
| 34 | INSRR | 1.41848128 |
| 35 | SIK1 | 1.35624382 |
| 36 | TESK1 | 1.35307115 |
| 37 | CDK12 | 1.33874284 |
| 38 | PRPF4B | 1.30858962 |
| 39 | MAP3K7 | 1.29367361 |
| 40 | DAPK2 | 1.29037960 |
| 41 | BUB1 | 1.21839768 |
| 42 | OXSR1 | 1.17420718 |
| 43 | KSR2 | 1.13713008 |
| 44 | TIE1 | 1.12523361 |
| 45 | STK38 | 1.09483814 |
| 46 | RAF1 | 1.09102312 |
| 47 | EPHA4 | 1.08129914 |
| 48 | MAP3K13 | 1.01392277 |
| 49 | MAP3K12 | 0.97391403 |
| 50 | MINK1 | 0.96832690 |
| 51 | RIPK1 | 0.96484471 |
| 52 | WNK3 | 0.93686456 |
| 53 | CDC7 | 0.93503462 |
| 54 | MAP3K9 | 0.93313335 |
| 55 | PRKD3 | 0.93310349 |
| 56 | FLT3 | 0.93010895 |
| 57 | PDPK1 | 0.92894861 |
| 58 | PAK3 | 0.92621509 |
| 59 | LIMK1 | 0.92259959 |
| 60 | PIK3CA | 0.92162229 |
| 61 | PDK1 | 0.90899930 |
| 62 | SGK3 | 0.90120016 |
| 63 | MAP2K7 | 0.89732618 |
| 64 | DMPK | 0.88270128 |
| 65 | CDK8 | 0.87234452 |
| 66 | DAPK1 | 0.85870568 |
| 67 | AKT2 | 0.85588458 |
| 68 | MAPK12 | 0.84515120 |
| 69 | KDR | 0.84064325 |
| 70 | PRKCH | 0.83673110 |
| 71 | BRSK1 | 0.81635498 |
| 72 | PRKAA1 | 0.81435076 |
| 73 | CAMKK1 | 0.81394618 |
| 74 | MAP2K2 | 0.80870240 |
| 75 | PAK4 | 0.79449136 |
| 76 | SGK223 | 0.79101048 |
| 77 | SGK494 | 0.79101048 |
| 78 | PAK6 | 0.78870618 |
| 79 | PRKAA2 | 0.78587427 |
| 80 | CAMK1D | 0.77775055 |
| 81 | SGK2 | 0.75899124 |
| 82 | CAMK2D | 0.74316856 |
| 83 | ERN1 | 0.74176255 |
| 84 | BRAF | 0.73927142 |
| 85 | MAP2K3 | 0.73676354 |
| 86 | TTK | 0.72247456 |
| 87 | MTOR | 0.71807054 |
| 88 | CCNB1 | 0.71600268 |
| 89 | TRPM7 | 0.69041241 |
| 90 | FGFR4 | 0.66859677 |
| 91 | CAMK2G | 0.66729444 |
| 92 | RET | 0.66635045 |
| 93 | AURKB | 0.64119831 |
| 94 | MAP3K8 | 0.63843457 |
| 95 | CAMK4 | 0.62606555 |
| 96 | MAPK11 | 0.62031578 |
| 97 | CAMK2A | 0.61368587 |
| 98 | CAMK1 | 0.61257951 |
| 99 | PRKACG | 0.60956069 |
| 100 | MUSK | 0.60919415 |
| 101 | CAMK2B | 0.60803245 |
| 102 | AURKA | 0.59754849 |
| 103 | TBK1 | 0.58440156 |
| 104 | MAP2K1 | 0.57454079 |
| 105 | CAMK1G | 0.56688909 |
| 106 | PTK6 | 0.56628654 |
| 107 | CDK4 | 0.56277768 |
| 108 | PRKD1 | 0.55020505 |
| 109 | PTK2B | 0.54650089 |
| 110 | GRK7 | 0.53628517 |
| 111 | MAP3K11 | 0.53009413 |
| 112 | TAOK2 | 0.52617073 |
| 113 | CAMKK2 | 0.52397547 |
| 114 | NEK6 | 0.51742099 |
| 115 | CDK7 | 0.51729905 |
| 116 | NME1 | 0.51687593 |
| 117 | STK24 | 0.50817256 |
| 118 | PTK2 | 0.50178006 |
| 119 | ILK | 0.49963640 |
| 120 | PRKCG | 0.49247213 |
| 121 | ABL2 | 0.49204806 |
| 122 | MAP2K6 | 0.47743456 |
| 123 | JAK2 | 0.47619991 |
| 124 | MST1R | 0.47500184 |
| 125 | DAPK3 | 0.46656552 |
| 126 | MAP3K5 | 0.46626457 |
| 127 | FRK | 0.46088566 |
| 128 | STK38L | 0.44858410 |
| 129 | PRKCI | 0.44528850 |
| 130 | ATR | 0.44476776 |
| 131 | ROCK1 | 0.44406558 |
| 132 | CDK5 | 0.44108405 |
| 133 | PRKACB | 0.43440983 |
| 134 | CDK19 | 0.41882162 |
| 135 | MAP3K1 | 0.39845450 |
| 136 | EPHB1 | 0.39670079 |
| 137 | PRKACA | 0.39262071 |
| 138 | FER | 0.39001204 |
| 139 | KSR1 | 0.38240023 |
| 140 | PAK1 | 0.37940388 |
| 141 | WNK1 | 0.37606695 |
| 142 | RPS6KA3 | 0.36390427 |
| 143 | NTRK1 | 0.35445839 |
| 144 | SGK1 | 0.35353973 |
| 145 | LATS2 | 0.35269735 |
| 146 | STK4 | 0.35207027 |
| 147 | NEK9 | 0.35118126 |
| 148 | PDGFRA | 0.34959986 |
| 149 | ERBB4 | 0.34655485 |
| 150 | CDC42BPA | 0.33911650 |
| 151 | MAPKAPK5 | 0.33864677 |
| 152 | CHEK1 | 0.32751607 |
| 153 | MAP3K2 | 0.32620074 |
| 154 | GRK5 | 0.31823689 |
| 155 | MAP3K3 | 0.31262935 |
| 156 | BMX | 0.28805063 |
| 157 | PRKG2 | 0.28619630 |
| 158 | CDK9 | 0.27326882 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.61398257 |
| 2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.85558041 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.49366261 |
| 4 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.43686806 |
| 5 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.11571841 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.98891428 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.81012903 |
| 8 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.56657630 |
| 9 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.54659334 |
| 10 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.50023484 |
| 11 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.41558864 |
| 12 | * Carbon metabolism_Homo sapiens_hsa01200 | 2.37703751 |
| 13 | DNA replication_Homo sapiens_hsa03030 | 2.29204611 |
| 14 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.17732159 |
| 15 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.02797981 |
| 16 | Sulfur relay system_Homo sapiens_hsa04122 | 1.97572271 |
| 17 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.97450232 |
| 18 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.91093250 |
| 19 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.80768084 |
| 20 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.73897162 |
| 21 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.73609763 |
| 22 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.66167289 |
| 23 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.66076524 |
| 24 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.57786014 |
| 25 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.53833770 |
| 26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.52298104 |
| 27 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.52024655 |
| 28 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.51424373 |
| 29 | Peroxisome_Homo sapiens_hsa04146 | 1.50556908 |
| 30 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.41743990 |
| 31 | * Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.37368621 |
| 32 | Base excision repair_Homo sapiens_hsa03410 | 1.35275580 |
| 33 | Mismatch repair_Homo sapiens_hsa03430 | 1.31989275 |
| 34 | Other glycan degradation_Homo sapiens_hsa00511 | 1.31464292 |
| 35 | Proteasome_Homo sapiens_hsa03050 | 1.29202823 |
| 36 | Parkinsons disease_Homo sapiens_hsa05012 | 1.29079474 |
| 37 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.24948277 |
| 38 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.20104118 |
| 39 | Bile secretion_Homo sapiens_hsa04976 | 1.16563551 |
| 40 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.09394614 |
| 41 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.04838227 |
| 42 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.03049180 |
| 43 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.02359003 |
| 44 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.02197477 |
| 45 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.93272020 |
| 46 | Alzheimers disease_Homo sapiens_hsa05010 | 0.92321425 |
| 47 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.92116335 |
| 48 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.88155655 |
| 49 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.86745528 |
| 50 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.84492528 |
| 51 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.84425375 |
| 52 | * Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.81471439 |
| 53 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.80203579 |
| 54 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.79193796 |
| 55 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.77630274 |
| 56 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.77342317 |
| 57 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.77050002 |
| 58 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.76763535 |
| 59 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.76410874 |
| 60 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.75840397 |
| 61 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.74470578 |
| 62 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.74414541 |
| 63 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.71989238 |
| 64 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.71737992 |
| 65 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.71690601 |
| 66 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.69262921 |
| 67 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.68557830 |
| 68 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.68161045 |
| 69 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.67041163 |
| 70 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.66850489 |
| 71 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.66686088 |
| 72 | Histidine metabolism_Homo sapiens_hsa00340 | 0.63989495 |
| 73 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.63929514 |
| 74 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.63566467 |
| 75 | Galactose metabolism_Homo sapiens_hsa00052 | 0.62303107 |
| 76 | Lysine degradation_Homo sapiens_hsa00310 | 0.61128438 |
| 77 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.61077680 |
| 78 | Insulin resistance_Homo sapiens_hsa04931 | 0.60418213 |
| 79 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.59945865 |
| 80 | Prion diseases_Homo sapiens_hsa05020 | 0.59835743 |
| 81 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.59612873 |
| 82 | Huntingtons disease_Homo sapiens_hsa05016 | 0.58367825 |
| 83 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.57310452 |
| 84 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.53682189 |
| 85 | GABAergic synapse_Homo sapiens_hsa04727 | 0.53182762 |
| 86 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.53086403 |
| 87 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.52797127 |
| 88 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.52708796 |
| 89 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.52665029 |
| 90 | ABC transporters_Homo sapiens_hsa02010 | 0.51877347 |
| 91 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.48125847 |
| 92 | Insulin secretion_Homo sapiens_hsa04911 | 0.47738498 |
| 93 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.44930556 |
| 94 | Purine metabolism_Homo sapiens_hsa00230 | 0.42499127 |
| 95 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.41241104 |
| 96 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.40046539 |
| 97 | Renin secretion_Homo sapiens_hsa04924 | 0.39703307 |
| 98 | Thyroid cancer_Homo sapiens_hsa05216 | 0.39648140 |
| 99 | Circadian entrainment_Homo sapiens_hsa04713 | 0.39180331 |
| 100 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.39107403 |
| 101 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.37989386 |
| 102 | Nicotine addiction_Homo sapiens_hsa05033 | 0.36082881 |
| 103 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.35461836 |
| 104 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.34558736 |
| 105 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.33431092 |
| 106 | Retinol metabolism_Homo sapiens_hsa00830 | 0.33382523 |
| 107 | Bladder cancer_Homo sapiens_hsa05219 | 0.33338119 |
| 108 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.33159012 |
| 109 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.32915407 |
| 110 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.32698386 |
| 111 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.32058540 |
| 112 | Olfactory transduction_Homo sapiens_hsa04740 | 0.32015543 |
| 113 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.31587820 |
| 114 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.31441078 |
| 115 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.30534797 |
| 116 | Salivary secretion_Homo sapiens_hsa04970 | 0.29997813 |
| 117 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.27625400 |
| 118 | Morphine addiction_Homo sapiens_hsa05032 | 0.27450358 |
| 119 | Cell cycle_Homo sapiens_hsa04110 | 0.27114038 |
| 120 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.26925749 |
| 121 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.25208547 |
| 122 | Long-term potentiation_Homo sapiens_hsa04720 | 0.24351284 |
| 123 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.23814764 |
| 124 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.22885955 |
| 125 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.22445903 |
| 126 | RNA transport_Homo sapiens_hsa03013 | 0.22197052 |
| 127 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.22173583 |
| 128 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.22152926 |
| 129 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.21581656 |
| 130 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.20836538 |
| 131 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.19421538 |
| 132 | Spliceosome_Homo sapiens_hsa03040 | 0.19247567 |

